Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A synthetic small molecule belonging to the class of organic compounds known as toluenes, characterized by a benzene ring bearing a methyl group and additional heterocyclic substituents. The compound features an imidazole core substituted at the 1-position with a 4-methylbenzyl group and at the 4-position with a thienyl (thiophene) moiety. It has been cataloged in chemical and drug databases as an experimental or discovery agent, but there is no evidence of clinical development, approved indications, or established pharmacological mechanism. Its molecular formula is C15H14N2S and its molecular weight is approximately 254.35 g/mol[1][3][8]. No information on mechanism of action, therapeutic use, or biological targets has been reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-(2-thienyl)-1-(4-methylbenzyl)-1h-imidazole.